117 related articles for article (PubMed ID: 16353670)
1. Growth restriction and exendin 4 promote endocrine expression in cultured islet cells derived from patients with persistent hyperinsulinemic hypoglycemia of infancy (PHHI).
Webb M; James RF
Endocr Res; 2005; 31(2):99-109. PubMed ID: 16353670
[TBL] [Abstract][Full Text] [Related]
2. Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy.
MacFarlane WM; Chapman JC; Shepherd RM; Hashmi MN; Kamimura N; Cosgrove KE; O'Brien RE; Barnes PD; Hart AW; Docherty HM; Lindley KJ; Aynsley-Green A; James RF; Docherty K; Dunne MJ
J Biol Chem; 1999 Nov; 274(48):34059-66. PubMed ID: 10567373
[TBL] [Abstract][Full Text] [Related]
3. Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential.
Linning KD; Tai MH; Madhukar BV; Chang CC; Reed DN; Ferber S; Trosko JE; Olson LK
Pancreas; 2004 Oct; 29(3):e64-76. PubMed ID: 15367896
[TBL] [Abstract][Full Text] [Related]
4. Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin release.
Masjkur J; Arps-Forker C; Poser SW; Nikolakopoulou P; Toutouna L; Chenna R; Chavakis T; Chatzigeorgiou A; Chen LS; Dubrovska A; Choudhary P; Uphues I; Mark M; Bornstein SR; Androutsellis-Theotokis A
J Biol Chem; 2014 Dec; 289(51):35503-16. PubMed ID: 25371201
[TBL] [Abstract][Full Text] [Related]
5. Persistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implications.
Alexandrescu S; Tatevian N; Olutoye O; Brown RE
Int J Clin Exp Pathol; 2010 Aug; 3(7):691-705. PubMed ID: 20830240
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evidence that culture in the high aspect rotating vessel can up-regulate hormone expression in growth dedifferentiated PHHI-derived islet cells.
Webb MA; Platton SL; Dennison AR; James RF
In Vitro Cell Dev Biol Anim; 2007; 43(7):210-4. PubMed ID: 17846858
[TBL] [Abstract][Full Text] [Related]
7. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Winzell MS; Ahrén B
J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
[TBL] [Abstract][Full Text] [Related]
8. Exendin 4 up-regulates expression of PDX 1 and hastens differentiation and maturation of human fetal pancreatic cells.
Movassat J; Beattie GM; Lopez AD; Hayek A
J Clin Endocrinol Metab; 2002 Oct; 87(10):4775-81. PubMed ID: 12364473
[TBL] [Abstract][Full Text] [Related]
9. Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes.
Bose B; Shenoy SP; Konda S; Wangikar P
Cell Biol Int; 2012 Nov; 36(11):1013-20. PubMed ID: 22897387
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin regulation of beta-cell function in the normal human fetuses and in neonates with persistent hyperinsulinemic hypoglycemia.
Otonkoski T; Andersson S; Simell O
J Clin Endocrinol Metab; 1993 Jan; 76(1):184-8. PubMed ID: 8093619
[TBL] [Abstract][Full Text] [Related]
11. Transient beneficial effects of exendin-4 treatment on the function of microencapsulated mouse pancreatic islets.
Bohman S; Waern I; Andersson A; King A
Cell Transplant; 2007; 16(1):15-22. PubMed ID: 17436851
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 increases the expression of hypoxia-inducible factor-1α in rat islets and preserves the endocrine cell volume of both free and macroencapsulated islet grafts.
Jia X; Sharma A; Kumagai-Braesch M; Wernerson AM; Sörenby AK; Yamamoto S; Wang F; Tibell AB
Cell Transplant; 2012; 21(6):1269-83. PubMed ID: 22405036
[TBL] [Abstract][Full Text] [Related]
13. In vivo treatment with glucagon-like peptide 1 promotes the graft function of fetal islet-like cell clusters in transplanted mice.
Suen PM; Li K; Chan JC; Leung PS
Int J Biochem Cell Biol; 2006; 38(5-6):951-60. PubMed ID: 16172015
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human islet-like structures generated from pancreatic precursor cells in culture.
Bodnar CA; Sen A; Kallos MS; Behie LA; Petropavlovskaia M; Rosenberg L
Biotechnol Bioeng; 2006 Apr; 93(5):980-8. PubMed ID: 16345100
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process.
Aviv V; Meivar-Levy I; Rachmut IH; Rubinek T; Mor E; Ferber S
J Biol Chem; 2009 Nov; 284(48):33509-20. PubMed ID: 19755420
[TBL] [Abstract][Full Text] [Related]
16. SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism.
Lithovius V; Saarimäki-Vire J; Balboa D; Ibrahim H; Montaser H; Barsby T; Otonkoski T
Diabetologia; 2021 Mar; 64(3):630-640. PubMed ID: 33404684
[TBL] [Abstract][Full Text] [Related]
17. Histologic findings in persistent hyperinsulinemic hypoglycemia of infancy: Australian experience.
Jack MM; Walker RM; Thomsett MJ; Cotterill AM; Bell JR
Pediatr Dev Pathol; 2000; 3(6):532-47. PubMed ID: 11000331
[TBL] [Abstract][Full Text] [Related]
18. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 protects rat islets against loss of viability and function induced by brain death.
Carlessi R; Lemos NE; Dias AL; Oliveira FS; Brondani LA; Canani LH; Bauer AC; Leitão CB; Crispim D
Mol Cell Endocrinol; 2015 Sep; 412():239-50. PubMed ID: 25976662
[TBL] [Abstract][Full Text] [Related]
20. Spexin Modulates Functions of Rat Endocrine Pancreatic Cells.
Sassek M; Kolodziejski PA; Strowski MZ; Nogowski L; Nowak KW; Mackowiak P
Pancreas; 2018 Aug; 47(7):904-909. PubMed ID: 29912854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
